Lonza Group AG (LZAGF)

Market Cap	42.52B
Revenue (ttm)	7.45B
Net Income (ttm)	637.66M
Shares Out	n/a
EPS (ttm)	8.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	572.14
Previous Close	575.60
Day's Range	569.25 - 600.23
52-Week Range	365.16 - 678.80
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 29, 2025

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substanc...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1897
• Employees: 18,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: LZAGF

Financial Performance

In 2023, Lonza Group AG's revenue was 6.72 billion, an increase of 7.94% compared to the previous year's 6.22 billion. Earnings were 654.00 million, a decrease of -46.17%.

Financial numbers in CHF